Per Ladenvall

2.0k total citations · 1 hit paper
31 papers, 1.1k citations indexed

About

Per Ladenvall is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Per Ladenvall has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 14 papers in Epidemiology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Per Ladenvall's work include Acute Ischemic Stroke Management (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Per Ladenvall is often cited by papers focused on Acute Ischemic Stroke Management (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Per Ladenvall collaborates with scholars based in Sweden, United States and Spain. Per Ladenvall's co-authors include Christina Jern, Hans Denison, Pierre Amarenco, S. Claiborne Johnston, Yongjun Wang, Carlos A. Molina, Scott Evans, Mikael Knutsson, Katarina Jood and Anders Himmelmänn and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Per Ladenvall

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA

2020 304 citations S. Claiborne Johnston, Pierre Amarenco et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Per Ladenvall Sweden	15	544	479	348	170	169	31	1.1k
Per-Gunnar Wiklund Sweden	15	427 0.8×	258 0.5×	97 0.3×	77 0.5×	57 0.3×	19	830
Dominick J. H. McCabe United Kingdom	22	738 1.4×	816 1.7×	993 2.9×	161 0.9×	214 1.3×	76	1.8k
Elena Sticchi Italy	21	155 0.3×	589 1.2×	446 1.3×	278 1.6×	39 0.2×	80	1.4k
Harinder S. Juneja United States	16	217 0.4×	348 0.7×	198 0.6×	177 1.0×	163 1.0×	54	1.3k
Rosmarie Leiderer Germany	15	227 0.4×	204 0.4×	126 0.4×	519 3.1×	59 0.3×	18	1.4k
P. Ferraresi Italy	19	192 0.4×	392 0.8×	192 0.6×	304 1.8×	232 1.4×	34	1.3k
Min Lin China	15	398 0.7×	158 0.3×	180 0.5×	394 2.3×	86 0.5×	33	1.0k
Xiaochuan Huo China	21	943 1.7×	147 0.3×	508 1.5×	155 0.9×	309 1.8×	102	1.6k
Kensaku Nishihira Japan	19	190 0.3×	460 1.0×	135 0.4×	403 2.4×	82 0.5×	94	1.3k
Alan C. Cameron United Kingdom	12	247 0.5×	311 0.6×	155 0.4×	80 0.5×	69 0.4×	31	756

Countries citing papers authored by Per Ladenvall

Since Specialization

Citations

This map shows the geographic impact of Per Ladenvall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Ladenvall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Ladenvall more than expected).

Fields of papers citing papers by Per Ladenvall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Ladenvall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Ladenvall. The network helps show where Per Ladenvall may publish in the future.

Co-authorship network of co-authors of Per Ladenvall

This figure shows the co-authorship network connecting the top 25 collaborators of Per Ladenvall. A scholar is included among the top collaborators of Per Ladenvall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Ladenvall. Per Ladenvall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horn, MacKenzie, Ondřej Volný, Hyun Seok Choi, et al.. (2024). Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleeding. Brain and Behavior. 14(5). e3481–e3481. 2 indexed citations

Johnston, S. Claiborne, Ritika Jain, Pierre Amarenco, et al.. (2023). Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial. BMJ Neurology Open. 5(2). e000478–e000478.

Concha, Mauricio, Lizhen Xu, MacKenzie Horn, et al.. (2023). Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most. SHILAP Revista de lepidopterología. 4(1). e000997–e000997. 4 indexed citations

Wang, Yongjun, Yuesong Pan, Hao Li, et al.. (2022). Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack. Neurology. 99(1). e46–e54. 7 indexed citations

Johnston, S. Claiborne, Pierre Amarenco, Hans Denison, et al.. (2021). Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. Stroke. 52(11). 3482–3489. 11 indexed citations

Evans, Scott, Mikael Knutsson, Pierre Amarenco, et al.. (2020). Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial. Clinical Trials. 17(6). 617–626. 13 indexed citations

Lesén, Eva, et al.. (2020). Age in relation to comorbidity and outcome in patients with high-risk TIA or minor ischemic stroke: A Swedish national observational study. European Stroke Journal. 6(1). 53–61. 3 indexed citations

Giang, Kok Wai, Per‐Olof Hansson, Carina U. Persson, et al.. (2020). Long-term risk of stroke and myocardial infarction in middle-aged men with a hypertensive response to exercise: a 44-year follow-up study. Journal of Hypertension. 39(3). 503–510. 5 indexed citations

Easton, J. Donald, Hans Denison, Scott Evans, et al.. (2019). Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial. International Journal of Stroke. 14(9). 908–914. 6 indexed citations

10.

Molina, Carlos A., S. Claiborne Johnston, Per Ladenvall, et al.. (2019). Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial. Stroke. 50(3). 675–682. 3 indexed citations

11.

Cucchiara, Brett, Scott E. Kasner, Mikael Knutsson, et al.. (2019). Disability after minor stroke and TIA. Neurology. 93(7). e708–e716. 34 indexed citations

12.

Wong, Ka Sing, Pierre Amarenco, Gregory W. Albers, et al.. (2018). Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial. Stroke. 49(7). 1678–1685. 18 indexed citations

13.

Ladenvall, Per, et al.. (2018). Quality of life after percutaneous closure of patent foramen ovale in patients after cryptogenic stroke compared to a normative sample. International Journal of Cardiology. 257. 46–49. 10 indexed citations

14.

Amarenco, Pierre, Gregory W. Albers, Hans Denison, et al.. (2017). Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. The Lancet Neurology. 16(4). 301–310. 119 indexed citations

15.

Ladenvall, Per, et al.. (2015). Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure. International Journal of Cardiology. 195. 293–299. 10 indexed citations

16.

Ladenvall, Per, et al.. (2013). Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA. Journal of Multidisciplinary Healthcare. 6. 357–357. 15 indexed citations

17.

Ladenvall, Per, Per‐Olof Hansson, Magnus Johansson, et al.. (2013). Seven-year follow-up of percutaneous closure of patent foramen ovale. PubMed. 1. 32–36. 5 indexed citations

18.

Ladenvall, Per, Björn Andersson, Christina Jern, et al.. (2013). Genetic variation at the human connexin 43 locus but not connexin 40 locus is associated with left bundle branch block. European Heart Journal. 34(suppl 1). P4960–P4960. 1 indexed citations

19.

Andersson, Jonas, Lars Johansson, Per Ladenvall, et al.. (2009). C-Reactive Protein Is a Determinant of First-Ever Stroke: Prospective Nested Case-Referent Study. Cerebrovascular Diseases. 27(6). 544–551. 43 indexed citations

20.

Ladenvall, Per, Staffan Nilsson, Katarina Jood, et al.. (2003). Genetic variation at the human tissue-type plasminogen activator (tPA) locus: haplotypes and analysis of association to plasma levels of tPA. European Journal of Human Genetics. 11(8). 603–610. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact